» Articles » PMID: 34970157

Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216

Abstract

Impairment of the arteries is a product of sustained exposure to various deleterious factors and progresses with time; a phenomenon inherent to vascular aging. Oxidative stress, inflammation, the accumulation of harmful agents in high cardiovascular risk conditions, changes to the extracellular matrix, and/or alterations of the epigenetic modification of molecules, are all vital pathophysiological processes proven to contribute to vascular aging, and also lead to changes in levels of associated circulating molecules. Many of these molecules are consequently recognized as markers of vascular impairment and accelerated vascular aging in clinical and research settings, however, for these molecules to be classified as biomarkers of vascular aging, further criteria must be met. In this paper, we conducted a scoping literature review identifying thirty of the most important, and eight less important, biomarkers of vascular aging. Herein, we overview a selection of the most important molecules connected with the above-mentioned pathological conditions and study their usefulness as circulating biomarkers of vascular aging.

Citing Articles

Developing technologies to assess vascular ageing: a roadmap from VascAgeNet.

Zanelli S, Agnoletti D, Alastruey J, Allen J, Bianchini E, Bikia V Physiol Meas. 2024; 45(12).

PMID: 38838703 PMC: 11697036. DOI: 10.1088/1361-6579/ad548e.


Mechanism of traditional Chinese medicine in elderly diabetes mellitus and a systematic review of its clinical application.

Zhang Q, Hu S, Jin Z, Wang S, Zhang B, Zhao L Front Pharmacol. 2024; 15:1339148.

PMID: 38510656 PMC: 10953506. DOI: 10.3389/fphar.2024.1339148.


Using the photoplethysmography method to monitor age-related changes in the cardiovascular system.

Djuric B, Zikic K, Nestorovic Z, Lepojevic-Stefanovic D, Milosevic N, Zikic D Front Physiol. 2023; 14:1191272.

PMID: 37538374 PMC: 10394700. DOI: 10.3389/fphys.2023.1191272.


The Role of Oxidative Stress and Antioxidants in Cardiovascular Comorbidities in COPD.

Miklos Z, Horvath I Antioxidants (Basel). 2023; 12(6).

PMID: 37371927 PMC: 10295232. DOI: 10.3390/antiox12061196.


Biomarkers of aging.

Bao H, Cao J, Chen M, Chen M, Chen W, Chen X Sci China Life Sci. 2023; 66(5):893-1066.

PMID: 37076725 PMC: 10115486. DOI: 10.1007/s11427-023-2305-0.


References
1.
Salisbury D, Bronas U . Reactive oxygen and nitrogen species: impact on endothelial dysfunction. Nurs Res. 2014; 64(1):53-66. DOI: 10.1097/NNR.0000000000000068. View

2.
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted.... Eur Heart J. 2012; 33(13):1635-701. DOI: 10.1093/eurheartj/ehs092. View

3.
Puel A, Casanova J . The nature of human IL-6. J Exp Med. 2019; 216(9):1969-1971. PMC: 6719420. DOI: 10.1084/jem.20191002. View

4.
Haycock P, Heydon E, Kaptoge S, Butterworth A, Thompson A, Willeit P . Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2014; 349:g4227. PMC: 4086028. DOI: 10.1136/bmj.g4227. View

5.
Wang M, Kim S, Monticone R, Lakatta E . Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis. Hypertension. 2015; 65(4):698-703. PMC: 4359070. DOI: 10.1161/HYPERTENSIONAHA.114.03618. View